Cargando…

Molecular Testing for Fragile X: Analysis of 5062 Tests from 1105 Fragile X Families—Performed in 12 Clinical Laboratories in Spain

Fragile X syndrome is the most common inherited form of intellectual disability. Here we report on a study based on a collaborative registry, involving 12 Spanish centres, of molecular diagnostic tests in 1105 fragile X families comprising 5062 individuals, of whom, 1655 carried a full mutation or w...

Descripción completa

Detalles Bibliográficos
Autores principales: Tejada, María-Isabel, Glover, Guillermo, Martínez, Francisco, Guitart, Miriam, de Diego-Otero, Yolanda, Fernández-Carvajal, Isabel, Ramos, Feliciano J., Hernández-Chico, Concepción, Pintado, Elizabet, Rosell, Jordi, Calvo, María-Teresa, Ayuso, Carmen, Ramos-Arroyo, María-Antonia, Maortua, Hiart, Milà, Montserrat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4058505/
https://www.ncbi.nlm.nih.gov/pubmed/24987673
http://dx.doi.org/10.1155/2014/195793
_version_ 1782321130341662720
author Tejada, María-Isabel
Glover, Guillermo
Martínez, Francisco
Guitart, Miriam
de Diego-Otero, Yolanda
Fernández-Carvajal, Isabel
Ramos, Feliciano J.
Hernández-Chico, Concepción
Pintado, Elizabet
Rosell, Jordi
Calvo, María-Teresa
Ayuso, Carmen
Ramos-Arroyo, María-Antonia
Maortua, Hiart
Milà, Montserrat
author_facet Tejada, María-Isabel
Glover, Guillermo
Martínez, Francisco
Guitart, Miriam
de Diego-Otero, Yolanda
Fernández-Carvajal, Isabel
Ramos, Feliciano J.
Hernández-Chico, Concepción
Pintado, Elizabet
Rosell, Jordi
Calvo, María-Teresa
Ayuso, Carmen
Ramos-Arroyo, María-Antonia
Maortua, Hiart
Milà, Montserrat
author_sort Tejada, María-Isabel
collection PubMed
description Fragile X syndrome is the most common inherited form of intellectual disability. Here we report on a study based on a collaborative registry, involving 12 Spanish centres, of molecular diagnostic tests in 1105 fragile X families comprising 5062 individuals, of whom, 1655 carried a full mutation or were mosaic, three cases had deletions, 1840 had a premutation, and 102 had intermediate alleles. Two patients with the full mutation also had Klinefelter syndrome. We have used this registry to assess the risk of expansion from parents to children. From mothers with premutation, the overall rate of allele expansion to full mutation is 52.5%, and we found that this rate is higher for male than female offspring (63.6% versus 45.6%; P < 0.001). Furthermore, in mothers with intermediate alleles (45–54 repeats), there were 10 cases of expansion to a premutation allele, and for the smallest premutation alleles (55–59 repeats), there was a 6.4% risk of expansion to a full mutation, with 56 repeats being the smallest allele that expanded to a full mutation allele in a single meiosis. Hence, in our series the risk for alleles of <59 repeats is somewhat higher than in other published series. These findings are important for genetic counselling.
format Online
Article
Text
id pubmed-4058505
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-40585052014-07-01 Molecular Testing for Fragile X: Analysis of 5062 Tests from 1105 Fragile X Families—Performed in 12 Clinical Laboratories in Spain Tejada, María-Isabel Glover, Guillermo Martínez, Francisco Guitart, Miriam de Diego-Otero, Yolanda Fernández-Carvajal, Isabel Ramos, Feliciano J. Hernández-Chico, Concepción Pintado, Elizabet Rosell, Jordi Calvo, María-Teresa Ayuso, Carmen Ramos-Arroyo, María-Antonia Maortua, Hiart Milà, Montserrat Biomed Res Int Research Article Fragile X syndrome is the most common inherited form of intellectual disability. Here we report on a study based on a collaborative registry, involving 12 Spanish centres, of molecular diagnostic tests in 1105 fragile X families comprising 5062 individuals, of whom, 1655 carried a full mutation or were mosaic, three cases had deletions, 1840 had a premutation, and 102 had intermediate alleles. Two patients with the full mutation also had Klinefelter syndrome. We have used this registry to assess the risk of expansion from parents to children. From mothers with premutation, the overall rate of allele expansion to full mutation is 52.5%, and we found that this rate is higher for male than female offspring (63.6% versus 45.6%; P < 0.001). Furthermore, in mothers with intermediate alleles (45–54 repeats), there were 10 cases of expansion to a premutation allele, and for the smallest premutation alleles (55–59 repeats), there was a 6.4% risk of expansion to a full mutation, with 56 repeats being the smallest allele that expanded to a full mutation allele in a single meiosis. Hence, in our series the risk for alleles of <59 repeats is somewhat higher than in other published series. These findings are important for genetic counselling. Hindawi Publishing Corporation 2014 2014-05-28 /pmc/articles/PMC4058505/ /pubmed/24987673 http://dx.doi.org/10.1155/2014/195793 Text en Copyright © 2014 María-Isabel Tejada et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Tejada, María-Isabel
Glover, Guillermo
Martínez, Francisco
Guitart, Miriam
de Diego-Otero, Yolanda
Fernández-Carvajal, Isabel
Ramos, Feliciano J.
Hernández-Chico, Concepción
Pintado, Elizabet
Rosell, Jordi
Calvo, María-Teresa
Ayuso, Carmen
Ramos-Arroyo, María-Antonia
Maortua, Hiart
Milà, Montserrat
Molecular Testing for Fragile X: Analysis of 5062 Tests from 1105 Fragile X Families—Performed in 12 Clinical Laboratories in Spain
title Molecular Testing for Fragile X: Analysis of 5062 Tests from 1105 Fragile X Families—Performed in 12 Clinical Laboratories in Spain
title_full Molecular Testing for Fragile X: Analysis of 5062 Tests from 1105 Fragile X Families—Performed in 12 Clinical Laboratories in Spain
title_fullStr Molecular Testing for Fragile X: Analysis of 5062 Tests from 1105 Fragile X Families—Performed in 12 Clinical Laboratories in Spain
title_full_unstemmed Molecular Testing for Fragile X: Analysis of 5062 Tests from 1105 Fragile X Families—Performed in 12 Clinical Laboratories in Spain
title_short Molecular Testing for Fragile X: Analysis of 5062 Tests from 1105 Fragile X Families—Performed in 12 Clinical Laboratories in Spain
title_sort molecular testing for fragile x: analysis of 5062 tests from 1105 fragile x families—performed in 12 clinical laboratories in spain
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4058505/
https://www.ncbi.nlm.nih.gov/pubmed/24987673
http://dx.doi.org/10.1155/2014/195793
work_keys_str_mv AT tejadamariaisabel moleculartestingforfragilexanalysisof5062testsfrom1105fragilexfamiliesperformedin12clinicallaboratoriesinspain
AT gloverguillermo moleculartestingforfragilexanalysisof5062testsfrom1105fragilexfamiliesperformedin12clinicallaboratoriesinspain
AT martinezfrancisco moleculartestingforfragilexanalysisof5062testsfrom1105fragilexfamiliesperformedin12clinicallaboratoriesinspain
AT guitartmiriam moleculartestingforfragilexanalysisof5062testsfrom1105fragilexfamiliesperformedin12clinicallaboratoriesinspain
AT dediegooteroyolanda moleculartestingforfragilexanalysisof5062testsfrom1105fragilexfamiliesperformedin12clinicallaboratoriesinspain
AT fernandezcarvajalisabel moleculartestingforfragilexanalysisof5062testsfrom1105fragilexfamiliesperformedin12clinicallaboratoriesinspain
AT ramosfelicianoj moleculartestingforfragilexanalysisof5062testsfrom1105fragilexfamiliesperformedin12clinicallaboratoriesinspain
AT hernandezchicoconcepcion moleculartestingforfragilexanalysisof5062testsfrom1105fragilexfamiliesperformedin12clinicallaboratoriesinspain
AT pintadoelizabet moleculartestingforfragilexanalysisof5062testsfrom1105fragilexfamiliesperformedin12clinicallaboratoriesinspain
AT roselljordi moleculartestingforfragilexanalysisof5062testsfrom1105fragilexfamiliesperformedin12clinicallaboratoriesinspain
AT calvomariateresa moleculartestingforfragilexanalysisof5062testsfrom1105fragilexfamiliesperformedin12clinicallaboratoriesinspain
AT ayusocarmen moleculartestingforfragilexanalysisof5062testsfrom1105fragilexfamiliesperformedin12clinicallaboratoriesinspain
AT ramosarroyomariaantonia moleculartestingforfragilexanalysisof5062testsfrom1105fragilexfamiliesperformedin12clinicallaboratoriesinspain
AT maortuahiart moleculartestingforfragilexanalysisof5062testsfrom1105fragilexfamiliesperformedin12clinicallaboratoriesinspain
AT milamontserrat moleculartestingforfragilexanalysisof5062testsfrom1105fragilexfamiliesperformedin12clinicallaboratoriesinspain